- Open
- 1874.00
- High
- 1889.50
- Low
- 1851.00
- Close
- 1865.50
- Change
- -7.00 (-0.37%)
- Volume
- 2,326,676
| 1 Sept 2026 | 15:00:00 | Total Voting Rights |
| 1 Sept 2026 | 07:00:14 | mRNA flu vaccine candidate to advance to phase III |
| 26 Aug 2026 | 15:30:00 | Director/PDMR Shareholding |
| 24 Aug 2026 | 15:30:00 | Director/PDMR Shareholding |
| 24 Aug 2026 | 07:02:01 | First global approval for Hibsago in Japan |
| 5 Mar 2026 | 2025 Annual Financial Report | |
| 27 Feb 2025 | 2024 Annual Financial Report | |
| 1 Mar 2024 | 2023 Annual Financial Report |
GSK plc is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines. It focuses on four core therapeutic areas: respiratory, immunology and inflammation, oncology, and infectious diseases. GSK operates globally and aims to impact the health of a significant number of people through its specialty medicines and vaccines.
Lord Hayward and Lord Balfe have interests in this issuer
| 1 Sept 2026 | 15:00:00 | Total Voting Rights |
| 1 Sept 2026 | 07:00:14 | mRNA flu vaccine candidate to advance to phase III |
| 26 Aug 2026 | 15:30:00 | Director/PDMR Shareholding |
| 24 Aug 2026 | 15:30:00 | Director/PDMR Shareholding |
| 24 Aug 2026 | 07:02:01 | First global approval for Hibsago in Japan |
| 5 Mar 2026 | 2025 Annual Financial Report | |
| 27 Feb 2025 | 2024 Annual Financial Report | |
| 1 Mar 2024 | 2023 Annual Financial Report |
GSK plc is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines. It focuses on four core therapeutic areas: respiratory, immunology and inflammation, oncology, and infectious diseases. GSK operates globally and aims to impact the health of a significant number of people through its specialty medicines and vaccines.
Lord Hayward and Lord Balfe have interests in this issuer
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £186.13bn | +0.0% | |
GSKGSK plc | £80.52bn | +0.3% |
| £1.68bn | -0.1% | |
| £1.55bn | -0.2% | |
| £38m | — | |
| £33m | -0.4% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £186.13bn | +0.0% | |
GSKGSK plc | £80.52bn | +0.3% |
| £1.68bn | -0.1% | |
| £1.55bn | -0.2% | |
| £38m | — | |
| £33m | -0.4% |
